2016
DOI: 10.1097/md.0000000000004267
|View full text |Cite
|
Sign up to set email alerts
|

Clinical features of Crohn disease concomitant with ankylosing spondylitis

Abstract: Extraintestinal manifestations (EIMs) cause increased morbidity and decreased quality of life in Crohn disease (CD). Ankylosing spondylitis (AS) belongs to EIMs. Very little is known on the clinical features of CD concomitant with AS. This study is to investigate the clinical features of CD patients with AS.We retrospectively collected all CD patients with AS in our hospital, and established a comparison group (CD without AS) with age, sex, and duration of Crohn disease matched. Clinical information was retrie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
15
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 38 publications
(39 reference statements)
2
15
1
Order By: Relevance
“…Two factors predictive of CD in association with SpA were higher disease activity, as reflected by the BASDAI, and increased FCP when not taking NSAID. Our findings are thus in keeping with other studies 44,50 . Anti-TNF therapy has been shown to induce and maintain remission of CD, while at the same time treating severe active SpA 51 , suggesting that it should be the preferred drug for the treatment of active and severe SpA associated with active or quiescent CD.…”
Section: Kopylov Et Al: the Space Capsule Studysupporting
confidence: 83%
“…Two factors predictive of CD in association with SpA were higher disease activity, as reflected by the BASDAI, and increased FCP when not taking NSAID. Our findings are thus in keeping with other studies 44,50 . Anti-TNF therapy has been shown to induce and maintain remission of CD, while at the same time treating severe active SpA 51 , suggesting that it should be the preferred drug for the treatment of active and severe SpA associated with active or quiescent CD.…”
Section: Kopylov Et Al: the Space Capsule Studysupporting
confidence: 83%
“…The most altered biological signs in our patients were:  CRP >11mg/L, Vs 1h (>7mm); 2h (>11mm) with nonsignificant association as reported by 14,15 .…”
Section: Discussionsupporting
confidence: 41%
“…and ). Then, 378 full texts were assessed for eligibility and, finally, 78 papers were included in the qualitative and quantitative analysis: 67 for the analysis of the prevalence of co‐existing IBD‐SpA (Tables and ) and only 11 for the diagnostic accuracy of red flags .…”
Section: Resultsmentioning
confidence: 99%